137 related articles for article (PubMed ID: 16879291)
1. Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control.
Küker W; Mader I; Nägele T; Uhl M; Adolph C; Klose U; Herrlinger U
Eur J Neurol; 2006 Aug; 13(8):819-26. PubMed ID: 16879291
[TBL] [Abstract][Full Text] [Related]
2. Imaging manifestations of progressive multifocal leukoencephalopathy.
Shah R; Bag AK; Chapman PR; Curé JK
Clin Radiol; 2010 Jun; 65(6):431-9. PubMed ID: 20451009
[TBL] [Abstract][Full Text] [Related]
3. [Neuroradiological study of a possible progressive multifocal leukoencephalopathy using diffusion tensor imaging and proton magnetic resonance spectroscopy].
Matsui N; Nakane S; Harada M; Furutani K; Izumi Y; Oka H; Hashimoto C; Kaji R
Rinsho Shinkeigaku; 2006 Aug; 46(8):555-60. PubMed ID: 17154035
[TBL] [Abstract][Full Text] [Related]
4. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.
McGuire D; Barhite S; Hollander H; Miles M
Ann Neurol; 1995 Mar; 37(3):395-9. PubMed ID: 7695239
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI.
Mader I; Herrlinger U; Klose U; Schmidt F; Küker W
Neuroradiology; 2003 Oct; 45(10):717-21. PubMed ID: 12942223
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Yousry TA; Pelletier D; Cadavid D; Gass A; Richert ND; Radue EW; Filippi M
Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
[TBL] [Abstract][Full Text] [Related]
7. [Neuroradiological study of progressive multifocal leukoencephalopathy associated with acquired immunodeficiency syndrome by MR imaging including diffusion-weighted imaging].
Uchibori A; Kobayashi Y; Chiba A; Tsuchiya K; Zheng HY; Yogo Y; Sakuta M
Rinsho Shinkeigaku; 2004 Aug; 44(8):531-6. PubMed ID: 15471089
[TBL] [Abstract][Full Text] [Related]
8. Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy.
Eisele P; Szabo K; Hornberger E; Griebe M; Hennerici MG; Kieseier BC; Gass A
J Neuroimaging; 2014; 24(4):425-8. PubMed ID: 23323645
[TBL] [Abstract][Full Text] [Related]
9. Conventional and diffusion-weighted MRI in progressive multifocal leukoencephalopathy: new elements for identification and follow-up.
da Pozzo S; Manara R; Tonello S; Carollo C
Radiol Med; 2006 Oct; 111(7):971-7. PubMed ID: 17021685
[TBL] [Abstract][Full Text] [Related]
10. A rational approach to PML for the clinician.
Calabrese L
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S38-41. PubMed ID: 22123934
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
12. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
13. Low signal intensity in U-fiber identified by susceptibility-weighted imaging in two cases of progressive multifocal leukoencephalopathy.
Miyagawa M; Maeda M; Umino M; Kagawa K; Nakamichi K; Sakuma H; Tomimoto H
J Neurol Sci; 2014 Sep; 344(1-2):198-202. PubMed ID: 24972818
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics, diagnostic criteria and treatment of progressive multifocal leukoencephalopathy].
Kuroda Y; Kosugi M
Nihon Rinsho; 2007 Aug; 65(8):1501-5. PubMed ID: 17695291
[TBL] [Abstract][Full Text] [Related]
15. Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.
Ono D; Shishido-Hara Y; Mizutani S; Mori Y; Ichinose K; Watanabe M; Tanizawa T; Yokota T; Uchihara T; Fujigasaki H
Neuropathology; 2019 Aug; 39(4):294-306. PubMed ID: 31155757
[TBL] [Abstract][Full Text] [Related]
16. Review of progressive multifocal leukoencephalopathy and natalizumab.
Aksamit AJ
Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
[TBL] [Abstract][Full Text] [Related]
17. Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Hodel J; Darchis C; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Zins M; Pruvo JP; Vermersch P; Leclerc X
Neurology; 2016 Apr; 86(16):1516-23. PubMed ID: 27009257
[TBL] [Abstract][Full Text] [Related]
18. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
[TBL] [Abstract][Full Text] [Related]
19. [Progressive multifocal leukoencephalopathy (PML). Report of a case diagnosed by amplification of JC virus DNA from cerebrospinal fluid (CSF)].
Ito D; Yogo Y; Okita H; Tanaka K; Koto A
Rinsho Shinkeigaku; 1998 Jan; 38(1):46-50. PubMed ID: 9597910
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy.
Cosottini M; Tavarelli C; Del Bono L; Doria G; Giannelli M; De Cori S; Michelassi MC; Bartolozzi C; Murri L
Eur Radiol; 2008 May; 18(5):1024-30. PubMed ID: 18324406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
